Moprolol is a non-selective beta-adrenergic receptor antagonist (commonly known as a beta-blocker) that was developed for the treatment of various cardiovascular conditions. It belongs to the class of older generation beta-blockers and interacts with both beta-1 and beta-2 adrenergic receptors.
Mechanism of Action
As a non-selective beta-blocker, moprolol exerts its therapeutic effects by competitively antagonizing beta-1 and beta-2 adrenergic receptors throughout the body.
- Beta-1 receptor blockade primarily affects the heart, leading to a decrease in heart rate (negative chronotropy), reduced myocardial contractility (negative inotropy), and diminished cardiac output. This action contributes to its antihypertensive and anti-anginal effects. It also reduces the secretion of renin from the kidneys, further contributing to blood pressure reduction.
- Beta-2 receptor blockade primarily affects the bronchial smooth muscles and peripheral blood vessels. In the bronchi, this can lead to bronchoconstriction, which is a concern for patients with respiratory conditions. In blood vessels, it can cause peripheral vasoconstriction.
Therapeutic Uses
Moprolol was historically prescribed for the management of several cardiovascular disorders, including:
- Hypertension: To lower elevated blood pressure.
- Angina Pectoris: To reduce the frequency and severity of chest pain associated with coronary artery disease, by decreasing the heart's oxygen demand.
- Cardiac Arrhythmias: To control abnormal heart rhythms, particularly those involving supraventricular tachycardias.
Due to the development of newer, often more selective (cardioselective) beta-blockers with improved side effect profiles, and other classes of cardiovascular drugs, moprolol's use has declined considerably in many regions. It is now rarely prescribed and may be discontinued in many pharmaceutical markets.
Side Effects
As with other beta-blockers, moprolol's side effect profile is related to its mechanism of action. Common side effects can include:
- Bradycardia (slow heart rate)
- Fatigue and weakness
- Dizziness
- Hypotension (low blood pressure)
- Gastrointestinal disturbances (e.g., nausea, diarrhea)
- Cold extremities
Due to its non-selective nature, moprolol also carries a higher risk of:
- Bronchospasm: Particularly in patients with asthma or chronic obstructive pulmonary disease (COPD).
- Masking symptoms of hypoglycemia: In diabetic patients, as it can blunt the adrenergic response to low blood sugar.
- Peripheral vasoconstriction: Which can exacerbate conditions like Raynaud's phenomenon.
Contraindications
Moprolol is contraindicated in individuals with:
- Severe bradycardia
- Second or third-degree atrioventricular (AV) block
- Cardiogenic shock
- Decompensated heart failure
- Severe bronchial asthma or severe COPD (due to the risk of bronchospasm)
- Prinzmetal's angina (due to potential for coronary vasoconstriction)